spacer
home > pmps > winter 2001 > lean compliance in manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lean Compliance in Manufacturing

This article looks at what life science companies can do to ensure that compliance activities do not become a bottleneck when production constraints are removed.

Today's Context
The race to get more new drugs to market faster continues. This race is a team event and all areas of the business must be part of the team. Discover more; prove more; get more NDAs; create a larger market; get the product flowing reliably into the marketplace - and all faster than before.

The reorganisation of businesses, both in response to and in anticipation of change, presents the opportunity to create the right processes with the right performance. This is significant to all pharmaceutical processes, given the volume of data, the need for good information in the right place at the right time, and the imperative of data security. When a world-leading ethical pharmaceutical company looked at the output of one of its factories, alarm bells began to ring.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Bruce Ramsay, Supply Chain Director at World Class International
Bruce Ramsay is Supply Chain Director at World Class International, a US- and European-based consultancy, specialising in process design, web technology and managed services in the pharmaceutical and high technology industries.

spacer
Bruce Ramsay
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Drive for generics sees Korea increasingly attractive to international pharma

Amsterdam, 31st July 2019: Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
More info >>

White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement